Headache pain

Journal of the American Osteopathic Association

Volumn 105, Issue 9 SUPPL. 4, 2005, Pages

  Gallagher, R Michael ^a,b  

^a University Headache Center   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; ANALGESIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTALBITAL; CAFFEINE; CONVULSANT AGENT; DICHLORALPHENAZONE; DIHYDROERGOTAMINE; ELETRIPTAN; ERGOTAMINE TARTRATE; FROVATRIPTAN; IBUPROFEN; ISOMETHEPTENE MUCATE; MUSCLE RELAXANT AGENT; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; PARACETAMOL; PROPRANOLOL; RIZATRIPTAN; SEROTONIN AGONIST; SUMATRIPTAN SUCCINATE; TIMOLOL MALEATE; TOPIRAMATE; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VALPROATE SEMISODIUM; ZOLMITRIPTAN;

APPETITE DISORDER; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CLUSTER HEADACHE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG FORMULATION; DRUG HALF LIFE; ENVIRONMENTAL FACTOR; FATIGUE; HISTORY OF MEDICINE; HUMAN; LETHARGY; MANIPULATIVE MEDICINE; MEDICAL EDUCATION; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; OSTEOPATHIC MEDICINE; OUTPATIENT CARE; PARESTHESIA; PHYSICAL EXAMINATION; PHYSICIAN; PROPHYLAXIS; SIDE EFFECT; SOCIAL PSYCHOLOGY; TENSION HEADACHE; TREATMENT PLANNING; WEIGHT REDUCTION; PRIMARY HEADACHE; PRIMARY HEALTH CARE; REVIEW;

HEADACHE DISORDERS, PRIMARY; HUMANS; OSTEOPATHIC MEDICINE; PRIMARY HEALTH CARE;

EID: 33644633017     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. National Headache Foundation. Chicago, Ill; 2004.
2. Blau JN, MacGregor EA. Migraine and the neck. Headache. 1993;34:88-90.
3. Stewart WF, Lipton RB, Simon D. Work related disability: results from the American Migraine Study. Cephalalgia. 1996;16:231-238.
4. Gallagher RM, Kunkel R. Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment. Headache. 2003;43:36-43.
5. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labor costs of migraine headache in the US. Pharmacoeconomics. 1992;2:67-76.
6. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalance and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
7. Gallagher RM. Precipitating causes of migraine. In: Diamond S, ed: Diamond's Migraine Headache Prevention and Management. New York, NY: Marcel Dekker; 1990:31-44.
8. Kidd BF, Nelson R. Musculoskeletal dysfunction of the neck in migraine and tension headache. Headache. 1993;33:566-569.
9. Ferrari MD, Roon KI, Lipton RB Goadsby PJ. Oral triptans (serotonin 5HT-1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001;358:1668-1675.
10. Gallagher RM. Ergotamine withdrawal causing "rebound headache." J Am Osteopath Assoc. 1983;82:677.
11. Gallagher RM. Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group. Arch Neurol. 1996;53:1285-1291.
12. Lipton RB, Stewart WF, Ryan RE Jr, Saper J, Silberstein S, Sheftell F. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating headache pain of an acute migraine attack: three double-blind, randomized, placebo-controlled trials. Arch Neurol. 1998;55:210-217.
13. Codispoti JR, Prior MJ, Fu M, Harte CM, Nelson EB. Efficacy of nonprescription doses of ibuprofen for treating migraine headache: a randomized controlled trial. Headache. 2001;41:665-679.
14. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol. 1982;33:335-341.
15. Diamond S. Medina JL. Double blind study of propranolol for migraine prophylaxis. Headache. 1976;16:24-27.
16. Stellar S, Ahrens SP, Meibohn AR, Reines SA. Migraine prevention with timolol. A double-blind crossover study. JAMA. 1984;252:2576-2580.
17. Sorensen KV. Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand. 1988;78:346-348.
18. Edwards KR, Glantz, MJ, Shea P, Norton, JA, Cross N. Topiramate for migraine prophylaxis: a double-blind, randomized, placebo controlled study. Headache. 2000;40:407.
19. Silberstein SD, Saper JR, Freitag FG. Migraine: diagnosis and treatment. In; Silberstein SD, Lipton RB, D'Alessio DJ, eds. Wolff's Headache and Other Head Pain. 7th ed. New York, NY: Oxford University Press; 2001:121-237
20. Ilkiss ML, Rentz LE. Neurology. In: Ward RC, ed. Foundations for Osteopathic Medicine. Baltimore, Md: Williams & Wilkins; 1997:401-416.
21. Ferrari MD. Biochemistry of tension-type headache. In: Olesen J, Schoenen J, eds. Tension-Type Headache: Classification, Mechanisms, and Treatment. New York, NY: Raven Presss; 1993:115-126.
22. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol. 1991;44:1147-1157.
23. Classification and the diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988;8(suppl 7):1-96.
24. Greenman PE. Manipulation and mobilization. In: Tollison CD, Kunkel RS, eds. Headache Diagnosis and Treatment. Baltimore, MD: Williams & Wilkins; 1993:347-355.
25. Mathew NT, Kurman R, Perez F. Drug induced refractory headache - clinical features and management. Headache. 1990;30:634-638.
26. Pearce JM. Chronic migrainous neuralgia: a variant of cluster headache. Brain. 1980;103:149-159.
27. Dodick DW, Campbell JK. Cluster headache: diagnosis, management, and treatment. In: Silberstein SD, Lipton RB, D'Alessio DJ, eds. Wolff's Headache and Other Head Pain. 7th ed. New York, NY: Oxford University Press; 2001:283-309.
28. Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache. 1981;21:1-4.